Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H van de Waterbeemd

Showing results (21-30 of 38) with videos related to

Pageof 4
Sort By:
Journal of Computer-Aided Molecular Design|June 1, 1989
Pattern recognition study of QSAR substituent descriptorsH van de Waterbeemd, N el Tayar, P A Carrupt, et al.
Journal of Medicinal Chemistry|April 20, 2001
Property-based design: optimization of drug absorption and pharmacokineticsH van De Waterbeemd, D A Smith, K Beaumont, et al.
Progress in Clinical and Biological Research|January 1, 1989
Beta-adrenoceptor modeling based on MEP studiesN el Tayar, H Van de Waterbeemd, P A Carrupt, et al.
Progress in Clinical and Biological Research|January 1, 1989
Multivariate data analyses of QSAR parametersH Van de Waterbeemd, B Testa, P A Carrupt, et al.
Journal of Medicinal Chemistry|December 1, 1987
Quantitative structure-activity relationships and eudismic analyses of the presynaptic dopaminergic activity and dopamine D2 and sigma receptor affinities of 3-(3-hydroxyphenyl)piperidines and octahydrobenzo[f]quinolinesH Van de Waterbeemd, N el Tayar, B Testa, et al.
Journal of Receptor Research|January 1, 1986
The binding of agonists and antagonists to rat lung beta-adrenergic receptors as investigated by thermodynamics and structure-activity relationshipsF Bree, N el Tayar, H Van de Waterbeemd, et al.
Journal of Drug Targeting|January 14, 1999
Estimation of blood-brain barrier crossing of drugs using molecular size and shape, and H-bonding descriptorsH van de Waterbeemd, G Camenisch, G Folkers, et al.
Progress in Clinical and Biological Research|January 1, 1989
Lipophilicity and conformational behaviour of substituted xanthinesB Walther, P A Carrupt, H Van de Waterbeemd, et al.
The Journal of Pharmacy and Pharmacology|September 1, 1988
Influence of lipophilicity and chirality on the selectivity of ligands for beta 1- and beta 2-adrenoceptorsN el Tayar, B Testa, H van de Waterbeemd, et al.
Drug Design and Delivery|December 1, 1987
Multivariate statistical analysis of L-dopa esters as potential anti-parkinsonian prodrugsH Van de Waterbeemd, B Testa, C Marrel, et al.
Pageof 4

Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
Journal of Computer-Aided Molecular Design|June 1, 1989
Pattern recognition study of QSAR substituent descriptorsH van de Waterbeemd, N el Tayar, P A Carrupt, et al.
Journal of Medicinal Chemistry|April 20, 2001
Property-based design: optimization of drug absorption and pharmacokineticsH van De Waterbeemd, D A Smith, K Beaumont, et al.
Progress in Clinical and Biological Research|January 1, 1989
Beta-adrenoceptor modeling based on MEP studiesN el Tayar, H Van de Waterbeemd, P A Carrupt, et al.
Progress in Clinical and Biological Research|January 1, 1989
Multivariate data analyses of QSAR parametersH Van de Waterbeemd, B Testa, P A Carrupt, et al.
Journal of Medicinal Chemistry|December 1, 1987
Quantitative structure-activity relationships and eudismic analyses of the presynaptic dopaminergic activity and dopamine D2 and sigma receptor affinities of 3-(3-hydroxyphenyl)piperidines and octahydrobenzo[f]quinolinesH Van de Waterbeemd, N el Tayar, B Testa, et al.
Journal of Receptor Research|January 1, 1986
The binding of agonists and antagonists to rat lung beta-adrenergic receptors as investigated by thermodynamics and structure-activity relationshipsF Bree, N el Tayar, H Van de Waterbeemd, et al.
Journal of Drug Targeting|January 14, 1999
Estimation of blood-brain barrier crossing of drugs using molecular size and shape, and H-bonding descriptorsH van de Waterbeemd, G Camenisch, G Folkers, et al.
Progress in Clinical and Biological Research|January 1, 1989
Lipophilicity and conformational behaviour of substituted xanthinesB Walther, P A Carrupt, H Van de Waterbeemd, et al.
The Journal of Pharmacy and Pharmacology|September 1, 1988
Influence of lipophilicity and chirality on the selectivity of ligands for beta 1- and beta 2-adrenoceptorsN el Tayar, B Testa, H van de Waterbeemd, et al.
Drug Design and Delivery|December 1, 1987
Multivariate statistical analysis of L-dopa esters as potential anti-parkinsonian prodrugsH Van de Waterbeemd, B Testa, C Marrel, et al.
Pageof 4